openPR Logo
Press release

Clinical Trial Market by Phases, Region, Companies, Global Forecast by 2026

07-05-2021 07:20 AM CET | Health & Medicine

Press release from: Renub Research

/ PR Agency: Renub Research
It expected that the Global Clinical Trials Market will expand, registering a CAGR of 14.13% during the forecast period, 2020-2026

It expected that the Global Clinical Trials Market will expand, registering a CAGR of 14.13% during the forecast period, 2020-2026

The clinical trial is a human medical study designed to test the safety and effectiveness of drugs, therapeutic products and devices before they are ultimately launched in the market. Around the world, the market is witnessing significant growth due to increasing R&D investment in pharmaceutical, life science and clinical research industries. Research centers and numerous organisations enhance clinical trials' productivity and effectiveness by advancing and managing clinical trials globally. According to our analysis, the Clinical Trials Market will reach the value of US$ 57.46 Billion by 2026.

After preclinical development, the investigational new drug passes through clinical phases I, II, III and IV during the clinical trial. These phases explain pharmacokinetics, pharmaco dynamics profile and side effect, which may be harmful or beneficial, adverse impact and post-marketing surveillance. Furthermore, as per our analysis, the market is anticipated to be dominated by Phase III, with Phase I expected to behold the fastest growth.

Factors Driving the Clinical Trials Industry Worldwide

The significant factors propelling the market of the global clinical trials market are increasing new medical equipment demand and medicines among end-users, coupled with growing investment for research and development activities for the development of effective medications. Moreover, the increasing number of individuals suffering from chronic diseases and evolving circumstances & nature of certain types of chronic diseases are other factors anticipated to support the growth of the global clinical trials market to a significant extent. It expected that the Global Clinical Trials Market will expand, registering a CAGR of 14.13% during the forecast period, 2020-2026.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=clinical-trials-market-p.php

By Indication

The Oncology segment held the most considerable market presence in the clinical trials market in 2020. Clinical trials are acting as the key to making progress against cancer. Today, people live longer lives from successful cancer treatments that are the results of past clinical trials. Clinical trials have helped to find new ways to prevent and detect cancer. And have also improved the quality of life for people during and after treatment. According to Renub Research, the Clinical Trials Market is valued at US$ 26.00 Billion in 2020.

By Study Designs - Global Clinical Trial Industry

The Interventional Design segment has the most prominent presence in the market. In addition, the Interventional Design in oncology is a rapidly growing sub-speciality that aims to develop new disease-modifying treatment options beyond conventional surgical and oncological therapies in several disease settings. The evidence for interventional oncology success dominated by single-arm study reporting technical success or clinical efficacy.

Clinical Trial Regions

North America is a conventional clinical trial region, and because of the legal, regulatory considerations, the clinical trial market shifted to developing nations. In the United States, the Clinical trials are funded and sponsored by the National Institute of Health (NIH), government agencies, academic groups, voluntary health organizations and industry.

The Asia-Pacific is emerging as a natural choice and ultimate destination for the clinical trial industry. Asia-Pacific has become the most preferred destination for global clinical trials because of significant cost advantage and other resource advantages combined with the unique benefits served by Asia Pacific's 3 'P's— Population, Patients and Physicians. Numerous pharmaceutical organizations and clinical research firms have started extracting the vast potential of Asia-Pacific and conducting clinical trials in Asia-Pacific on a big scale.

The report has also analyzed the competitive landscape of the following key players: ICON Plc, Wuxi AppTec, SGS SA, Syneos Health and PRA Health Sciences Inc. Our research shows that there will be a notable increase in the efficiency and effectiveness of clinical trials in the coming years.

Disruptions Caused Due to the Coronavirus Crisis:

The COVID-19 pandemic has remarkably impacted the global market for clinical trials, as there has been a rising focus on developing new therapeutics or vaccines to curb or operate the disease. Also, COVID-19 has induced a slight shift in terms of the way clinical trials performed.

Earlier, the global clinical trial space had been experiencing an increased interest in virtual/decentralized trials. The virtual/decentralized trials have also highlighted on conference agendas and magazine articles for a long time. Finally, with the COVID-19 outbreak, the trials have been forced to move to a virtual model to keep them on track during this pandemic situation.

Renub Research latest report titled "Global Clinical Trial Market by Phases (1, 2, 3, 4), Indications (Autoimmune/Inflammation, Pain management, Oncology, CNS Condition Diabetes, Obesity ,Cardiovascular, Others), Study design (Interventional Trial Market, Observational Trial Market, Expanded Access Trial Market), Region (North America, Europe, Asia Pacific , Latin America, Middle East & Africa), Company (ICON Plc, Wuxi AppTec, SGS SA, Syneos Health, PRA Health Sciences Inc)" provides a detailed analysis of Clinical Trial Industry.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/clinical-trials-market-p.php

Phases – Clinical Trials Market breakup from 4 viewpoints:

1. Phase 1
2. Phase 2
3. Phase 3
4. Phase 4

Indications – Clinical Trials Market breakup from 8 viewpoints:

1. Autoimmune/Inflammation
2. Pain management
3. Oncology
4. CNS Condition
5. Diabetes
6. Obesity
7. Cardiovascular
8. Others

Study Designs – Clinical Trials Market breakup from 3 viewpoints:

1. Interventional Trial Market
2. Observational Trial Market
3. Expanded Access Trial Market

Region – Clinical Trials Market breakup from 5 viewpoints:

1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. Middle East & Africa

The Companies Covered have been covered from 3 viewpoints:

• Overview
• Recent Developments
• Revenue

Companies Covered:

1. ICON Plc
2. Wuxi AppTec
3. SGS SA
4. Syneos Health
5. PRA Health Sciences Inc

Industry Related Opportunity:

United States Generic Drugs Market: https://www.renub.com/united-states-generic-drugs-market-p.php

Allergic Conjunctivitis Market: https://www.renub.com/allergic-conjunctivitis-market-p.php

United States Specialty Pharmaceuticals Market: https://www.renub.com/united-states-specialty-pharmaceuticals-market-p.php

Australia Diabetes Market: https://www.renub.com/australia-diabetes-market-p.php

CAR T Cell Therapy Market: https://www.renub.com/car-t-cell-therapy-market-p.php

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers, and executives to make informed and correct decisions.

Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research

Roswell, GA 30076

Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Market by Phases, Region, Companies, Global Forecast by 2026 here

News-ID: 2320889 • Views:

More Releases from Renub Research

Global Chocolate Market Analysis, Size, Share, Growth ⅼ Forecast (2024 - 2032) ⅼ Renub Research
Global Chocolate Market Analysis, Size, Share, Growth ⅼ Forecast (2024 - 2032) …
Global Chocolate Market Size was US$132.65 billion in 2023 and is expected to reach to US$196.79 billion by 2032. It is predicted to expend at a CAGR of 4.48% from 2024 to 2032. Chocolate is a beloved treat worldwide and has been for hundreds of years. The worldwide chocolate industry is worth billions of dollars, and new trends are continuously emerging. Chocolate liquor and cocoa cream are used to make
Global Automotive Air Suspension Market, Size, Share, Growth ⅼ Forecast (2024 - 2032) ⅼ Renub Research
Global Automotive Air Suspension Market, Size, Share, Growth ⅼ Forecast (2024 …
Global Automotive Air Suspension Market value is expected to be about US$ 11.20 Billion by 2032. The CAGR for the automotive air suspension market from 2024 to 2032 is 6.05%. Renub Research stated that it was valued at US$ 6.60 Billion in 2023. During World War II, the US developed an air suspension system, especially for heavier aircraft. Air suspension was first developed as a lightweight, compact construction method. A vehicle
Saudi Arabia Chocolate Market Size, Share, Growth ⅼ Forecast (2024 -2032) ⅼ Renub Research
Saudi Arabia Chocolate Market Size, Share, Growth ⅼ Forecast (2024 -2032) ⅼ …
Saudi Arabia chocolate market was US$ 1,0.5.68 Million in 2023 and it is projected to reach US$ 1,585.03 Million by 2032 with a CAGR of 4.73% from 2024 to 2032. The intake of goodies in Saudi Arabia reflects changing market tends and evolving cultural values. Saudi Arabia boasts of being the largest market for chocolates, and its annual consumption has been increasing at a rate of 5.5%, indicating its developing
Saudi Arabia Contact Lenses Market Analysis, Size, Share, Growth ⅼ Forecast (2024 - 2032) ⅼ Renub Research
Saudi Arabia Contact Lenses Market Analysis, Size, Share, Growth ⅼ Forecast (2 …
According to Renub Research, Saudi Arabia contact lens market was worth US$115.79 Million in 2023 and is anticipated to reach US$ 212.88 Million by 2032, developing at a CAGR of 7% from 2024 to 2032. The Saudi Arabian contact lens market is increasing because of the rising occurrence of ocular diseases, increasing awareness about the blessings of contact lenses, and the desire for daily disposable lenses. The market is regulated to

All 5 Releases


More Releases for Trial

Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, by trial phase …
"The Report Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2017" provides an overview of Bioabsorbable Stents (BAS) currently in pipeline stage. Get Sample copy of this Report @ ​https://www.marketresearchreports.biz/sample/sample/1326359 The report provides
Cardiac Pacemakers - Medical Devices Pipeline Assessment, by trial phase, trial …
"The Report Cardiac Pacemakers - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​Cardiac Pacemakers - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, Cardiac Pacemakers - Medical Devices Pipeline Assessment, 2017" provides an overview of Cardiac Pacemakers currently in pipeline stage. Get Sample copy of this Report @ ​https://www.marketresearchreports.biz/sample/sample/1326358 The report provides comprehensive information on the
Renal Denervation Catheters - Medical Devices Pipeline Assessment, by trial phas …
"The Report Renal Denervation Catheters - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​Renal Denervation Catheters - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, Renal Denervation Catheters - Medical Devices Pipeline Assessment, 2017" provides an overview of Renal Denervation Catheters currently in pipeline stage. Get Sample copy of this Report @ ​https://www.marketresearchreports.biz/sample/sample/1326356 The report provides
Tissue Heart Valves - Medical Devices Pipeline Assessment, by trial phase, trial …
"The Report Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017" provides an overview of Tissue Heart Valves currently in pipeline stage. Get Sample copy of this Report @ ​https://www.marketresearchreports.biz/sample/sample/1326355 The report provides
Deep Brain Stimulators - Medical Devices Pipeline Assessment, by trial phase, tr …
"The Report Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017" provides an overview of Deep Brain Stimulators currently in pipeline stage. Get Sample copy of this Report @ ​https://www.marketresearchreports.biz/sample/sample/1326353 The report provides